Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gion

Showing results (1-10 of 121) with videos related to

Pageof 13
Sort By:
The International Journal of Biological Markers|April 18, 2003
Prognostic and predictive molecular markers: are we ready for their clinical use? The opinion of a clinical biochemistM Gion
Breast (Edinburgh, Scotland)|February 18, 2004
Serum tumour markers: from quality control to total quality managementM Gion
The International Journal of Biological Markers|February 6, 2004
Prostate cancer screening policy in Italy. A statement endorsed by twenty scientific societies: towards unanimous consentM Gion
Journal of the National Cancer Institute|September 7, 2000
More about: prognostic importance of low c-erbB2 expression in breast tumorsR Dittadi, M Gion
Cancer Journal (Sudbury, Mass.)|July 6, 2000
Molecular-targeted anticancer therapy: challenges related to study design and choice of proper endpointsG Gasparini, M Gion
The International Journal of Biological Markers|October 11, 2003
Interchangeability between control material and patient serum in tumor biomarker assessmentR Dittadi, M Gion
European Journal of Cancer (Oxford, England : 1990)|November 16, 2004
Circulating biomarkers from tumour bulk to tumour machinery: promises and pitfallsM Gion, M G Daidone
The International Journal of Biological Markers|February 17, 2017
editor's commentsM Gion, A S C Fabricio
Hormone and Metabolic Research. Supplement Series|January 1, 1981
Glucosylated hemoglobin and reduced erythrocyte deformability in diabetesD E McMillan, K M Gion
The International Journal of Biological Markers|July 17, 2008
Editor's comments: the role of inflammation in the development and progression of cancerM Gion, A S C Fabricio
Pageof 13

Showing results (1-10 of 121) with videos related to

Sort By:
Pageof 13
The International Journal of Biological Markers|April 18, 2003
Prognostic and predictive molecular markers: are we ready for their clinical use? The opinion of a clinical biochemistM Gion
Breast (Edinburgh, Scotland)|February 18, 2004
Serum tumour markers: from quality control to total quality managementM Gion
The International Journal of Biological Markers|February 6, 2004
Prostate cancer screening policy in Italy. A statement endorsed by twenty scientific societies: towards unanimous consentM Gion
Journal of the National Cancer Institute|September 7, 2000
More about: prognostic importance of low c-erbB2 expression in breast tumorsR Dittadi, M Gion
Cancer Journal (Sudbury, Mass.)|July 6, 2000
Molecular-targeted anticancer therapy: challenges related to study design and choice of proper endpointsG Gasparini, M Gion
The International Journal of Biological Markers|October 11, 2003
Interchangeability between control material and patient serum in tumor biomarker assessmentR Dittadi, M Gion
European Journal of Cancer (Oxford, England : 1990)|November 16, 2004
Circulating biomarkers from tumour bulk to tumour machinery: promises and pitfallsM Gion, M G Daidone
The International Journal of Biological Markers|February 17, 2017
editor's commentsM Gion, A S C Fabricio
Hormone and Metabolic Research. Supplement Series|January 1, 1981
Glucosylated hemoglobin and reduced erythrocyte deformability in diabetesD E McMillan, K M Gion
The International Journal of Biological Markers|July 17, 2008
Editor's comments: the role of inflammation in the development and progression of cancerM Gion, A S C Fabricio
Pageof 13